Publication | Open Access

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

MedicinePathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology